The diagnostic field is undergoing a quiet revolution, driven by the convergence of nanotechnology and acoustic sensing. This review, for the first time, captures this transformative shift, charting the rise of nanostructured Quartz Crystal Microbalance (QCM) biosensors from a specialized research tool into a versatile, high-performance platform poised to redefine point-of-care diagnostics. We explore how the strategic integration of nanomaterials – such as gold nanoparticles, magnetic beads, and 2D composites - directly overcomes the traditional limitations of QCM, unlocking unprecedented sensitivity, specificity, and robustness in complex biological media. By acting as dynamic signal amplifiers and smart interfaces, these nanostructures enable the detection of elusive, low-abundance biomarkers critical for early disease intervention, from cancer antigens and neuroinflammatory signals to viral pathogens. This work provides a synthesized analysis of the underlying principles, material innovations, and diagnostic applications that define this emerging frontier. We highlight how nano-engineering transforms QCM into a label-free, real-time sensing platform capable of revealing conventional laboratory methods. Furthermore, we critically assess the translational pathway of these technologies, addressing key challenges and future directions for integration into portable, affordable, and clinically validated diagnostic devices. Ultimately, this review illuminates nano-structured QCM biosensors not merely as an incremental improvement, but as a foundational technology bridging the gap between centralized laboratories and the urgent need for decentralized, actionable health insights. • Nanostructured QCM biosensors overcome traditional sensitivity and selectivity limitations through engineered nanomaterial interfaces. • Gold nanoparticles, magnetic beads, and 2D composites enhance mass loading, surface area, and signal amplification for low-abundance biomarker detection. • Applications span cancer diagnostics, pathogen detection, neurodegenerative disease monitoring, and real-time glucose sensing. • Advanced QCM techniques (QCM-D and QCM-R) enable viscoelastic analysis and improved performance in complex biological media. • Future integration with AI, IoT, and portable systems aims to bridge lab-based diagnostics and decentralized, actionable health insights.
Darbandi et al. (2026) studied this question.